Sirius XM Radio (Nasdaq: SIRI) reported earnings yesterday. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Sirius XM Radio met expectations on revenues and missed expectations on earnings per share.

Compared to the prior-year quarter, revenue increased and GAAP earnings per share expanded.

Margins expanded across the board.

Revenue details
SIRIUS XM Radio chalked up revenue of $785.7 million. The 10 analysts polled by S&P Capital IQ predicted revenue of $786.6 million. GAAP sales were 6.5% higher than the prior-year quarter's $735.9 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.00. The nine earnings estimates compiled by S&P Capital IQ forecast $0.01 per share on the same basis. GAAP EPS were $0.01 for Q4 against -$0.02 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 61.8%, 140 basis points better than the prior-year quarter. Operating margin was 34.6%, 1,680 basis points better than the prior-year quarter. Net margin was 9.1%, 2,020 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $803.8 million. On the bottom line, the average EPS estimate is $0.02.

Next year's average estimate for revenue is $3.36 billion. The average EPS estimate is $0.06.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 4,422 members out of 5,377 rating the stock outperform, and 955 members rating it underperform. Among 778 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 561 give Sirius XM Radio a green thumbs-up, and 217 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Sirius XM Radio is outperform, with an average price target of $2.38.